Monitor outcomes to ensure long-term PRRS control success. Track diagnostic results and pig performance data across sow, grow-finish, and whole production systems to detect low-level virus circulation, guide decisions, and move herds toward stable or negative status.
The Guilty Gilt Guide was written with a clear objective – to maximize the whole-herd performance of pig populations by helping gilts to reach their full reproductive potential and produce healthy pigs that reach their full genetic potential during grow-finish.
The open reading frames (ORF)5 represents approximately 4% of the porcine repro- ductive and respiratory syndrome virus (PRRSV)-2 genome (whole-PRRSV) and is often determined by the Sanger technique, which rarely detects >1 PRRSV strain if present in the sample.
Porcine reproductive and respiratory syndrome virus (PRRSV) is an important swine pathogen affecting the global swine industry.
Vaccination with porcine reproductive and respiratory syndrome (PRRS) Type 2 modified- live vaccines (MLVs) has been shown to improve clinical signs and survival rates in PRRS virus (PRRSV)-challenged pigs.
Highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) known as pig high fever disease was first reported in China and has spread rapidly in neighboring southeastern Asian countries.
The use of Ingelvac PRRS® vaccines can significantly reduce lung lesions following challenge with heterologous PRRSV isolates (86-94% ORF5 nucleotide similarity) in the three-week-old pig respiratory challenge model.
Disease associated with Porcine Reproductive and Respiratory Virus (PRRS) continues to be a major problem in all swine producing regions.